A new test for genetic markers that can identify which lumps in the thyroid gland are cancerous and which are harmless – potentially preventing unneeded operations – will make its debut Oct. 1 for patients seeking care ...
Oct 1, 2013
0
0
Scientists at St. Jude Children's Research Hospital are studying the combined effect of cancer treatments and inherited mutations in DNA-repair genes. Their results may help predict which survivors are at increased risk of ...
Jun 4, 2020
0
1
A new analysis has found that adolescents and young adults who develop thyroid cancer as a secondary cancer have a significantly greater risk of dying than those with primary thyroid cancer. Published early online in Cancer, ...
Feb 24, 2014
0
0
For those who think that space exploration offers no tangible benefits for those of us on earth, a new research discovery involving thyroid cancer may prove otherwise. In a new report appearing in the February 2014 issue ...
Jan 30, 2014
0
0
More Americans exposed to radiation caused by the government would be compensated under a bill that passed the U.S. Senate Thursday.
Mar 8, 2024
0
5
(HealthDay)—U.S. Food and Drug Administration approval for the anti-cancer drug Nexavar (sorafenib) has been expanded to include late-stage differentiated thyroid cancer, the most common type of thyroid cancer.
Nov 24, 2013
0
0
Combining a gene-targeted drug, a cancer-bursting virus and a drug that removes the immune system's brake pedal can tackle thyroid cancer with newfound gusto, research has found.
Dec 8, 2020
0
19
To the list of oncogenic drivers of lung cancer that includes ALK, EGFR, ROS1 and RET, results of a University of Colorado Cancer Center study presented at ASCO 2013 show that mutations in the gene NTRK1 cause a subset of ...
Jun 3, 2013
0
0
A panel of 19 microRNAs identified using next-generation sequencing could categorize indeterminate thyroid nodule samples into malignant and benign.
Jul 26, 2018
0
3
The FDA has approved a thyroid cancer drug successfully tested at Virginia G. Piper Cancer Center Clinical Trials, a partnership of Scottsdale Healthcare and the Translational Genomics Research Institute (TGen).
Mar 27, 2013
0
0
